Skip to content

Characteristics of blood microorgannisms in patients with atherosclerotic cardiovascular disease

Characteristics of blood microorgannisms in patients with atherosclerotic cardiovascular disease

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098719
Enrollment
Unknown
Registered
2025-03-12
Start date
2024-07-12
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerotic cardiovascular disease

Interventions

Healthy control group:NA
ASCVD patient group:NA

Sponsors

Qingdao Traditional Chinese Medicine Hospital (Haici hospital)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. It meets the diagnostic criteria of healthy volunteers and ASCVD patients, and is confirmed by a professional physician in the inpatient medical record. 2. Complete archives, with repeated and traceable hospitalization records/outpatient records/flow records, medication records, follow-up records. 3. Subjects who agreed to participate in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Systemic diseases with intrinsic inflammatory response (such as inflammatory bowel disease, systemic lupus erythematosus, etc.); 2. Vegetarians or people with irregular diet and serious eating behavior disorders; 3. Chronic anti-inflammatory therapy with steroids and/or non-steroidal anti-inflammatory drugs or prior antibiotic therapy within the past 3 months; 4. Persons who abuse alcohol or drugs out of control. 5. Patients who have participated in other clinical trials within the last 3 months.

Design outcomes

Primary

MeasureTime frame
Blood microbial sequencing;

Secondary

MeasureTime frame
Traditional Chinese Medicine Symptoms, Signs, Tongue Symptoms, Pulse Symptoms;Blood cells and classification indicators;Blood biochemistry and other indicators;lymphocyte subsets detection;immune-inflammatory factors;coagulation function;Myocardial enzyme spectrum,Myocardial damage markers, and cardiac function markers;

Countries

China

Contacts

Public ContactJiang Ting

Qingdao Traditional Chinese Medicine Hospital (Haici Hospital)

jiangting@qdu.edu.cn+86 137 3099 8269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026